The influence of antimicrobial agents on macrophage-associated Staphylococcus aureus

Acta Pathol Microbiol Immunol Scand B. 1985 Jun;93(3):189-94. doi: 10.1111/j.1699-0463.1985.tb02875.x.

Abstract

Macrophages obtained by culturing human blood monocytes were incubated with Staphylococcus aureus for phagocytosis to occur and exposed to gentamicin, rifampin, clindamycin or trimethoprim/sulphamethoxazole. The macrophage-associated bacteria were protected against gentamicin at low concentrations (1 mg/l) and trimethoprim/sulphamethoxazole. However, high concentrations of gentamicin and clindamycin reduced the number of bacteria, indicating that these drugs penetrated into human macrophages and killed phagocytosed bacteria. Rifampin, even at low concentrations (0.5 mg/l), caused a marked reduction in macrophage-associated bacteria, implying that the drug penetrated into the phagocytes and retained its effect in the cells most effectively.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Cells, Cultured
  • Clindamycin / pharmacology
  • Drug Combinations / pharmacology
  • Drug Interactions
  • Gentamicins / pharmacology
  • Humans
  • Macrophages / drug effects
  • Macrophages / immunology
  • Macrophages / microbiology*
  • Phagocytosis*
  • Rifampin / pharmacology
  • Staphylococcus aureus / drug effects*
  • Staphylococcus aureus / immunology
  • Sulfamethoxazole / pharmacology
  • Trimethoprim / pharmacology
  • Trimethoprim, Sulfamethoxazole Drug Combination

Substances

  • Anti-Bacterial Agents
  • Drug Combinations
  • Gentamicins
  • Clindamycin
  • Trimethoprim, Sulfamethoxazole Drug Combination
  • Trimethoprim
  • Sulfamethoxazole
  • Rifampin